Theresa Westphal
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 03, 2022
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer.
Journal: NPJ precision oncology
Published: February 25, 2021
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Journal: Breast care (Basel, Switzerland)
Published: July 30, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.
Journal: Journal of clinical medicine
Published: April 26, 2020
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 21, 2020
Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.
Journal: Scottish medical journal
Published: July 21, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
Journal: Journal of clinical medicine
Published: May 28, 2019
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Journal: Breast cancer research : BCR
Published: August 27, 2018
Last Updated: 09/26/2026